Optimizing the Strategic Value of Competitive Intelligence

Competitive intelligence teams occupy a unique position within pharmaceutical and biotech businesses. They interact with a wide range of stakeholders and can support countless strategic initiatives with their insight. But there are challenges; supporting disparate groups of stakeholders with competing priorities is tough and it’s easy for CI teams to lose focus or provide disproportionate […]

Share:

Competitive intelligence teams occupy a unique position within pharmaceutical and biotech businesses. They interact with a wide range of stakeholders and can support countless strategic initiatives with their insight.

But there are challenges; supporting disparate groups of stakeholders with competing priorities is tough and it’s easy for CI teams to lose focus or provide disproportionate focus on the loudest voices.

In this report we investigate common pitfalls and provide guidance on how to optimize your CI work streams. Equip your team with the knowledge and tools needed to elevate your CI capabilities and demonstrate your strategic value across the organization.

Key Highlights:

  • Early Stakeholder Inclusion: Techniques for engaging stakeholders from the outset to ensure CI outputs are relevant and actionable.
  • Dynamic Program Design: Strategies to keep your CI programs flexible and responsive to changing market conditions and organizational priorities.
  • Strategic Focus: Frameworks for aligning key intelligence questions with business needs to deliver impactful insights.
  • Case Studies and Best Practices: Real-world examples and practical advice to enhance the strategic value of your CI outputs.

Upcoming Webinar

World Preview 2026

Tuesday 16th June 2026 | 3pm BST

By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.

Related Posts